“Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting: 52-Week Data From the Phase 4 ARTISTYK Study”. SKIN The Journal of Cutaneous Medicine, vol. 9, no. 6, Nov. 2025, p. s649, https://doi.org/10.25251/7j9e8h28.